MX9605253A - An injectable analgesic therapeutic pharmaceutical composition, for intramuscular administration. - Google Patents

An injectable analgesic therapeutic pharmaceutical composition, for intramuscular administration.

Info

Publication number
MX9605253A
MX9605253A MX9605253A MX9605253A MX9605253A MX 9605253 A MX9605253 A MX 9605253A MX 9605253 A MX9605253 A MX 9605253A MX 9605253 A MX9605253 A MX 9605253A MX 9605253 A MX9605253 A MX 9605253A
Authority
MX
Mexico
Prior art keywords
pharmaceutical composition
intramuscular administration
injectable
analgesic
nimesulide
Prior art date
Application number
MX9605253A
Other languages
Spanish (es)
Other versions
MXPA96005253A (en
Inventor
Amarjit Singh
Rajesh Jain
Original Assignee
Panacea Biotec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panacea Biotec Ltd filed Critical Panacea Biotec Ltd
Priority to MX9605253A priority Critical patent/MX9605253A/en
Publication of MXPA96005253A publication Critical patent/MXPA96005253A/en
Publication of MX9605253A publication Critical patent/MX9605253A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

This invention describes an injectable, analgesic, therapeutic, pharmaceutical composition, for intramuscular administration, containing Nimesulide for intramuscular administration. Composition comprises Nimesulide and a parenteral absorption increasing vehicle/base. Parenteral absorption increasing vehicle/base comprises dimethylacetamide, benzyl benzoate, benzyl alcohol, ethyl oleato. A process for an injectable, analgesic, therapeutic, pharmaceutical composition manufacturing, containing Nimesulide, is also described. Composition shows a remarkable analgesic activity and it is very effective and useful for acute pain conditions treatment, such as post-operative trauma, cancer-associated pain, sportive lesions and the like.
MX9605253A 1996-10-30 1996-10-30 An injectable analgesic therapeutic pharmaceutical composition, for intramuscular administration. MX9605253A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX9605253A MX9605253A (en) 1996-10-30 1996-10-30 An injectable analgesic therapeutic pharmaceutical composition, for intramuscular administration.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX9605253A MX9605253A (en) 1996-10-30 1996-10-30 An injectable analgesic therapeutic pharmaceutical composition, for intramuscular administration.

Publications (2)

Publication Number Publication Date
MXPA96005253A MXPA96005253A (en) 1998-04-01
MX9605253A true MX9605253A (en) 1998-04-30

Family

ID=39427803

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9605253A MX9605253A (en) 1996-10-30 1996-10-30 An injectable analgesic therapeutic pharmaceutical composition, for intramuscular administration.

Country Status (1)

Country Link
MX (1) MX9605253A (en)

Similar Documents

Publication Publication Date Title
CA2188703A1 (en) Therapeutic injectable analgesic pharmaceutical composition containing nimesulide 4-nitro, 2-phenoxyphenyl methane sulphonamide for intramuscular administration
AU7031500A (en) Therapeutic quinazoline compounds
AU3136897A (en) Compositions, methods and devices for the transdermal delivery of drugs
AU5981098A (en) Therapeutic gestagens for the treatment of premenstrual dysphoric disorder
EP1870103A3 (en) Use of uridine in combination with choline for the treatment of memory disorders
AU3153097A (en) Pharmaceutical for treatment of neurological and neuropsychiatric disorders
IL112969A0 (en) Pharmaceutical composition comprising t-cell actiVator for the treatment of cancer
WO2001049275A3 (en) Methods and compositions for mitigating pain using nitrate esters
AU2508597A (en) Drug for the treatment of tumours
UA70919C2 (en) Composition for treating and preventing arterial thrombosis based on selective inhibitors of factor xa alone or in combination with compounds possessing anti-platelet aggregation activity
WO1998008505A8 (en) Pharmaceutical compounds
GB9212308D0 (en) Therapeutic compositions
BR9500436A (en) Products use of a g-csf use of a tnf protein ligand process for the treatment and / or prevention of septic shock
EP0663835A1 (en) Use of parathormone, of its biologically active fragments and of related peptides for treatment of pregnancy.
WO2001072685A3 (en) Polyamine analogues as cytotoxic agents
WO1996030042A3 (en) Methods of treating inflammation and compositions therefor
ES2174533T3 (en) USE OF A MIXTURE OF A DIOL AND AN ALFA-HYDROXY ACID FOR THE TREATMENT OF HYPERQUERATOTIC SKIN DISEASES.
AU2162700A (en) Supramolecular complexes containing therapeutic agents
GB9907571D0 (en) Compounds
AU6624896A (en) Pharmaceutical composition
MX9605253A (en) An injectable analgesic therapeutic pharmaceutical composition, for intramuscular administration.
AU3600199A (en) A pharmaceutical composition containing ezrin mutated on tyrosine 353
WO1999056697A3 (en) Pharmaceutical composition
WO2001009165A8 (en) ACTIVATION OF PEPTIDE PRODRUGS BY hK2
EP0906757A3 (en) Analgesic composition comprising moxonidine and an opioid analgesic agent

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees